Palbociclib Combined with Endocrine Treatment in Hormone Receptor-Positive, HER2-negative Breast Cancer Patients with High Relapse Risk after Neoadjuvant Chemotherapy: Subgroup Analyses of Premenopausal Patients in PENELOPE-B
ESMO OPEN（2024）
关键词
early breast cancer,hormone receptor positive,HER2 negative,adjuvant CDK4/6 inhibitor,palbociclib,premenopausal,PENELOPE-B,ovarian function
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要